Impact of variability on the choice of biosimilarity limits in assessing follow-on biologics.
about
Scientific factors and current issues in biosimilar studies.Avoiding ambiguity with the Type I error rate in noninferiority trials.Biosimilars: where we were and where we are.A Calibrated Power Prior Approach to Borrow Information from Historical Data with Application to Biosimilar Clinical Trials.Sample size calculations for the development of biosimilar products.
P2860
Impact of variability on the choice of biosimilarity limits in assessing follow-on biologics.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Impact of variability on the c ...... assessing follow-on biologics.
@en
Impact of variability on the c ...... assessing follow-on biologics.
@nl
type
label
Impact of variability on the c ...... assessing follow-on biologics.
@en
Impact of variability on the c ...... assessing follow-on biologics.
@nl
prefLabel
Impact of variability on the c ...... assessing follow-on biologics.
@en
Impact of variability on the c ...... assessing follow-on biologics.
@nl
P2093
P2860
P356
P1476
Impact of variability on the c ...... assessing follow-on biologics.
@en
P2093
Laszlo Endrenyi
Shein-Chung Chow
P2860
P304
P356
10.1002/SIM.5567
P407
P577
2012-08-30T00:00:00Z